Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.9%

2 terminated/withdrawn out of 29 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed trials have results

Key Signals

6 recruiting2 with results

Enrollment Performance

Analytics

Phase 1

25(86.2%)

N/A

2(6.9%)

Phase 2

1(3.4%)

Early Phase 1

1(3.4%)

29Total

Phase 1(25)

N/A(2)

Phase 2(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials

NCT05691361Phase 1Active Not Recruiting

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Role: collaborator

NCT05858736Phase 1Active Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Role: collaborator

NCT05293145Not ApplicableCompleted

AVANCE-Houston Building Futures Program Evaluation

Role: collaborator

NCT07455578Phase 1Not Yet Recruiting

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Role: collaborator

NCT05261802Not ApplicableCompleted

AVANCE-Houston FRAMEWorks Program Evaluation

Role: collaborator

NCT07327359Phase 1Recruiting

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Role: collaborator

NCT07430059Phase 1Not Yet Recruiting

Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant

Role: collaborator

NCT06302426Phase 1Recruiting

Trial of INI-4001 in Patients With Advanced Solid Tumours

Role: collaborator

NCT06038279Phase 1Completed

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Role: collaborator

NCT07165067Phase 1Recruiting

A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors

Role: collaborator

NCT06899230Phase 1Active Not Recruiting

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Role: collaborator

NCT05643118Phase 1Completed

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

Role: collaborator

NCT06798454Phase 1Completed

Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)

Role: collaborator

NCT06965881Phase 1Terminated

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

Role: collaborator

NCT06975605Phase 1Completed

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Role: collaborator

NCT05670379Phase 1Completed

Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant

Role: collaborator

NCT06659757Phase 1Completed

A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects

Role: collaborator

NCT06877611Phase 1Recruiting

A Phase 1 Study of S-4321